Seres Therapeutics
MCRB
#10155
Rank
โ‚ฌ44.77 M
Marketcap
4,62ย โ‚ฌ
Share price
0.57%
Change (1 day)
-56.07%
Change (1 year)

EPS for Seres Therapeutics (MCRB)

EPS in 2026 (TTM): 0,55ย โ‚ฌ

According to Seres Therapeutics's latest financial reports the company's current EPS (TTM) is 0,31ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 0,56ย โ‚ฌ an increase over its 2024 EPS that were of N/A.

EPS history for Seres Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)0,55ย โ‚ฌ-1.24%
20250,56ย โ‚ฌ
2024N/A-100%
2023-15,56ย โ‚ฌ-61.54%
2022-40,45ย โ‚ฌ220.83%
2021-12,61ย โ‚ฌ-35.71%
2020-19,61ย โ‚ฌ-9.68%
2019-21,71ย โ‚ฌ-48.97%
2018-42,55ย โ‚ฌ9.95%
2017-38,70ย โ‚ฌ-3.91%
2016-40,28ย โ‚ฌ-1.29%
2015-40,80ย โ‚ฌ285.48%
2014-10,58ย โ‚ฌ157.99%
2013-4,10ย โ‚ฌ42.44%
2012-2,88ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Xencor
XNCR
-2,01ย โ‚ฌ-754.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Agios Pharmaceuticals
AGIO
-6,09ย โ‚ฌ-2,085.71%๐Ÿ‡บ๐Ÿ‡ธ USA